Corticosteroid treatment exacerbates bone osteopenia in mice with gonadal hormone deficiency–induced osteoporosis

2017 ◽  
Vol 105 ◽  
pp. 41-46 ◽  
Author(s):  
Riadh Badraoui ◽  
Nahed Amri ◽  
Nourhène Zammel ◽  
Rim Chaabane ◽  
Tarek Rebai
1987 ◽  
Vol 25 (19) ◽  
pp. 73-75

Prolonged treatment with a corticosteroid, unless to replace hormone deficiency, carries well recognised risks which include hypertension, hyperglycaemia, osteoporosis and cushingoid appearance. Moreover, doses above 5–7.5mg prednisolone daily can suppress the hypothalamo-pituitary-adrenal (HPA) axis. Needlessly high doses should therefore be avoided and treatment should be withdrawn when it is no longer needed. Many unwanted effects then disappear or cease to progress - though osteoporosis may persist and the child whose growth has been suppressed may not fully catch up. Disease relapse is the commonest difficulty during or following withdrawal of corticosteroid treatment. This article discusses some other problems that may arise.


2021 ◽  
Author(s):  
Rui Peng ◽  
Wen Dai ◽  
Di Li ◽  
Yan Li

Abstract Backgrounds: Gonadal hormone deficiency is associated with the development of depression, but what mediates this association is unclear. To test the possibility that it reflects neuroimmune and neuroinflammatory processes, we analyzed how gonadal hormone deficiency and replacement affect microglial activation and inflammatory response during the development of depressive symptomatology in gonadectomized male mice. Methods: Adult male ICR mice received gonadectomy. Gonadal hormone levels, neuroinflammation, mciroglial activation and depressive behaviors were evaluated 7 days, 14 days, and 30 days later. Furthermore, the neuroprotective mechanism of treatment with testosterone and estradiol on depressive symptomatology were also observed.Results: Testosterone level and the ratio of testosterone to estradiol in the serum and brain tissue of mice exposed to 3-35 days of chronic unpredictable stress were much lower than in control animals. Gonadal hormone sustained deficiency in gonadectomized mice and subsequent led to acute inflammation at day 7 following castration. Activating microglia in mice exposed to 7 days of castration subsequently suppressed the proliferation of microglia, such that their numbers in hippocampus and cortex were lower than the numbers in sham-operated mice after 30 days of castration. Here, we showed that gonadal hormone deficiency induces Traf6-mediated microglia activation, a type of inflammatory mediator. Microglia treated in this way for long time showed down-regulation of activation markers, abnormal morphology and depressive-like behaviors. Restoration and maintenance of a fixed ratio of testosterone to estradiol significantly suppressed microglial activation, neuronal necroptosis, dramatically inducing hippocampal neurogenesis and reducing depressive behaviors via the suppression of Traf6/TAK1 pathway. Conclusions: These findings suggest that activated or immunoreactive microglia contribute to gonadal hormone deficiency-induced depression, as well as testosterone and estradiol exert synergistic anti-depressant effects via suppressing microglial activaton in gonadectomized male mice, possibly through Traf6 signaling.


Sign in / Sign up

Export Citation Format

Share Document